Cite Filings / PLX / 0001558370-21-008019

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Protalix BioTherapeutics, Inc. Filed 2021-06-04 Acc 0001558370-21-008019

Documents 1

DEF 14A Proxy Statement , tmb-20210707xdef14a.htm

Around this filing

2021-09-30 DEF 14A Proxy Statement
2021-06-04 DEF 14A Proxy Statement
2021-06-03 4 10% owner sold 918,717 shares at an average $2.27 ($2,088,857)
2021-06-02 8-K Other events
2020-04-15 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tmb-20210707xdef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…